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ABSTRACT
Background
Despite the comprehensive World Health Organization (WHO)/United Nations Children’s
Fund (UNICEF) measles mortality–reduction strategy and the Measles Initiative, a partnership of
international organizations supporting measles mortality reduction in Africa, certain high-
burden countries continue to face recurrent epidemics. To our knowledge, few recent studies
have documented measles mortality in sub-Saharan Africa. The objective of our study was to
investigate measles mortality in three recent epidemics in Niamey (Niger), N’Djamena (Chad),
and Adamawa State (Nigeria).
Methods and Findings
We conducted three exhaustive household retrospective mortality surveys in one
neighbourhood of each of the three affected areas: Boukoki, Niamey, Niger (April 2004, n ¼
26,795); Moursal, N’Djamena, Chad (June 2005, n¼21,812); and Dong District, Adamawa State,
Nigeria (April 2005, n ¼ 16,249), where n is the total surveyed population in each of the
respective areas. Study populations included all persons resident for at least 2 wk prior to the
study, a duration encompassing the measles incubation period. Heads of households provided
information on measles cases, clinical outcomes up to 30 d after rash onset, and health-seeking
behaviour during the epidemic. Measles cases and deaths were ascertained using standard
WHO surveillance-case definitions. Our main outcome measures were measles attack rates
(ARs) and case fatality ratios (CFRs) by age group, and descriptions of measles complications
and health-seeking behaviour. Measles ARs were the highest in children under 5 y old (under 5
y): 17.1% in Boukoki, 17.2% in Moursal, and 24.3% in Dong District. CFRs in under 5-y-olds were
4.6%, 4.0%, and 10.8% in Boukoki, Moursal, and Dong District, respectively. In all sites, more
than half of measles cases in children aged under 5 y experienced acute respiratory infection
and/or diarrhoea in the 30 d following rash onset. Of measles cases, it was reported that 85.7%
(979/1,142) of patients visited a health-care facility within 30 d after rash onset in Boukoki,
73.5% (519/706) in Moursal, and 52.8% (603/1,142) in Dong District.
Conclusions
Children in these countries still face unacceptably high mortality from a completely
preventable disease. While the successes of measles mortality–reduction strategies and
progress observed in measles control in other countries of the region are laudable and evident,
they should not overshadow the need for intensive efforts in countries that have just begun
implementation of the WHO/UNICEF comprehensive strategy.
The Editors’ Summary of this article follows the references.
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Very signiﬁcant progress in measles control has been made
over the past decade in Africa. The World Health Organ-
ization (WHO) and the United Nations Children’s Fund
(UNICEF) have developed a comprehensive strategy for
sustainable measles mortality reduction, with the goal of a
90% reduction in global measles deaths (compared with 2000
levels) by 2010. The four-pronged strategy focuses on
improved routine immunization, providing all children with
a second opportunity for measles immunization through
either periodic supplemental immunization activities (SIAs)
or a routine second dose of measles vaccine, improved
measles case management, and careful measles surveillance
[1]. The launch of the Measles Initiative in 2001 has helped in
the progress made. Partners in the initiative include: the
American Red Cross, the United Nations Foundation, the
Centers for Disease Control (United States), WHO, and
UNICEF. In recent years, measles mortality has declined
substantially in Africa: an estimated 216,000 measles deaths in
the WHO African Region in 2004 compared with 519,000 in
1999 [2].
Despite this achievement, measles remains a leading cause
of mortality in children under 5 y old in some sub-Saharan
countries. Failure to deliver at least one dose of measles
vaccine remains the primary reason for high measles mortal-
ity. Recurrent large epidemics continue in those countries
that have not fully implemented the WHO/UNICEF compre-
hensive strategy. Measles epidemics generally occur in cycles,
often with 1–3 y of relatively low incidence followed by an
epidemic, commonly lasting 6 mo or more. The disease is a
viral respiratory infection and affected children may suffer
lifelong disabilities, including brain damage and blindness;
fatalities result from complications including diarrhoea and
pneumonia. To our knowledge, only a limited number of
recent studies have been published on measles mortality
during epidemics in high-burden African countries (see, for
example, [3]), and recent reports focus on the success of the
WHO/UNICEF measles mortality–reduction activities [4–9].
Here, we attempt to ﬁll this information gap by examining
measles morbidity and mortality in three epidemics in high-
burden African countries.
Over the past several years, Epicentre/Me ´decins Sans
Frontie `res (MSF) have been involved in the investigation of
and response to measles epidemics in Niamey, Niger (2003–
2004), Adamawa State, Nigeria (2004–2005), and N’Djamena,
Chad (2004–2005). All three countries have chronically low
immunization coverage and weak health systems; their
populations are among the world’s poorest; and they are
identiﬁed as priorities for measles mortality reduction by the
WHO/UNICEF strategic plan. All three countries have a
routine measles vaccination schedule that aims to provide
infants with a single dose at 9 mo of age, with no formal
second opportunity for measles vaccination. Before the
epidemics, SIA ‘‘catch-up’’ campaigns had yet to be con-
ducted in any of these countries. Measles vaccination cover-
age in children aged under 5 y was estimated to be 33% in
N’Djamena, Chad (Epicentre vaccination coverage survey,
unpublished data); 70.9% in Niamey, Niger (Epicentre
vaccination coverage survey [10]); and 22% (administrative
data) in the north-eastern part of Nigeria where the epidemic
in Adamawa State occurred [11].
At the beginning of each epidemic, at least ten cases were
laboratory-conﬁrmed by the respective Ministries of Health
through detection of measles-speciﬁc IgM antibodies in sera
collected after rash onset, following the WHO measles
surveillance protocol [12]. Measles was diagnosed clinically
using the standard WHO surveillance-case deﬁnition [13,14],
and laboratory conﬁrmation was not routinely performed.
MSF implemented outbreak-response immunization (Nia-
mey and N’Djamena) and/or enhanced case management
(Niamey, Adamawa State, and N’Djamena) in collaboration
with the respective Ministries of Health. Vaccination activ-
ities were organized in Niamey and N’Djamena during the
epidemics, taking place 24 wk and 22 wk after the beginning
of the epidemic, respectively. A 1-wk campaign in Niamey
targeted 50% of children aged between 6 mo and 59 mo living
in the city, and in N’Djamena, a mass measles vaccination
campaign targeted all children aged between 6 mo and 59
mo—both campaigns were implemented regardless of pre-
vious vaccination or disease history. Vaccine coverage
subsequently reached 84.8% in Niamey [10] and 80.6% in
N’Djamena (Epicentre, unpublished data). Reinforced clinical
case management included training, provision of treatment
kits comprising antibiotics, paracetamol, vitamin A, and oral
rehydration salts. In all sites, strengthening of clinical case
management, together with free access to treatment, was
implemented at least 16 wk after the epidemic was detected
(22 wk in Niamey, 18 wk in Adamawa State, and 16 wk in
N’Djamena). In total, 10,880 cases were reported in Niamey,
8,015 cases in N’Djamena, and 2,505 cases in Adamawa State.
Each of the three epidemics lasted for more than 6 mo.
We conducted exhaustive household retrospective mortal-
ity surveys in one neighbourhood of each of the three
affected areas. The objective was to estimate measles age-
speciﬁc attack rates (ARs) and case fatality ratios (CFRs),
frequency of measles-related complications, and access to
health care during these epidemics in order to provide a
picture of measles morbidity and mortality in high-burden
settings.
Methods
With the agreement and collaboration of the respective
Ministries of Health, Epicentre conducted three exhaustive
household retrospective mortality surveys in Boukoki, Nia-
mey (Niger); Moursal, N’Djamena (Chad); and Dong District,
Demsa Local Government Area (Adamawa State, Nigeria).
Niamey and N’Djamena are urban areas, whereas Demsa
Local Government Area is a rural area.
Each neighbourhood covered a population of at least
16,000 persons according to the most recent population
census. This population size was considered sufﬁcient to
investigate at least 500 measles cases, thereby allowing for an
estimated measles CFR of 5% with a precision of 6 2.3% as
described in the WHO protocol for determining measles
CFRs in a community [15]. Site selection was based on rapid
assessments carried out by ﬁeld teams as well as discussions
with health workers and community leaders. In addition to
sufﬁcient population size, clear administrative boundaries
and feasibility issues (e.g., accessibility and the absence of
major security concerns) were important selection criteria.
An epidemic was deﬁned as an increase in measles cases
during a 3-wk period above the number normally expected
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recall period covered the time from the beginning of the
epidemic until the start of the survey and was approximately
6 mo in all three sites (197 d in Boukoki, 184 d in Moursal,
and 175 d in Dong District). The starting date coincided with
the ﬁrst day of Ramadan in Boukoki, the Ramadan mid-point
in Dong District, and the ﬁrst day of the year in Moursal.
These dates provided an easily memorable event, and
calendars of local events were used to facilitate date recall.
For all surveys, teams of interviewers visited every house-
hold in the study area. After completing the interview, the
survey team left a mark on the house gate to ensure that all
houses were visited and to avoid double counting. We asked
for the help of neighbours to trace absentees and re-visited
empty (but not abandoned) households later in the day. If
during the second visit the occupants could not be found or if
they refused to participate, that household was skipped.
Interviewers conducted face-to-face interviews with heads of
households, or, if they were absent, with the most senior adult
household member. A household was deﬁned as a group of
people sleeping in the same house and sharing meals every
day for at least the previous 2 wk. Oral, informed consent was
obtained from all respondents before the interviews started.
Standardized, pre-piloted questionnaires were used and
interviews were conducted in local language(s).
For each household, we collected demographic data
including sex and age (under 5 y, 5–14 y, and 15 y and over)
at the end of the recall period and used this information as
our denominator for the calculation of ARs. Measles cases
were ascertained using the standard WHO clinical case
deﬁnition: any person presenting with a history of fever
and generalized macular-papular rash and at least one of
coryza, cough, or conjunctivitis [13,14]. When measles cases
were identiﬁed in a household, respondents provided
information on age in months or years, sex, measles
complications, disease outcome (dead or alive), and health-
seeking behaviour. We considered two common complica-
tions, respiratory infections and diarrhoea, which were
attributed to measles if they occurred within 30 d of rash
onset. Respondents were asked whether children had a cough
and/or breathing difﬁculties. Diarrhoeal complications were
based on the WHO deﬁnition for diarrhoea [12].
For each death reported as being measles-related, we
veriﬁed that the death met the following WHO deﬁnition:
death in a person meeting the measles case deﬁnition within
30 d of rash onset, unless there was another clearly stated
non-related cause [12]. Post-measles deaths occurring more
than 30 d after rash onset were also estimated for the recall
period. Place of death (house or health-care facility) was
documented for each measles-associated death. It was not
possible to corroborate deaths with death certiﬁcates, as
declaration of deaths is not a common practice in the
investigated populations.
Data were entered into EpiData version 3.0 (EpiData
Association, http://www.epidata.dk) and analyzed using Epi-
Info version 3.3 (CDC, http://www.cdc.gov). Measles ARs are
expressed as measles cases per 100 persons, using the survey
population as the denominator. Measles CFRs are expressed as
measles deaths occurring within 30 d of rash onset per 100
cases, with a follow-up of at least 30 d. We also examined the
CFRs for all measles-related deaths that occurred during the
recall period, expressed as measles deaths occurring during
therecall periodper 100cases,with a follow-up of at least30d.
Results
Epidemic curves and the timing of the surveys are shown in
Figures 1–3. Each survey took place when the epidemic was
subsiding. Characteristics of study populations are represen-
tative of those expected in this region of Africa (Table 1).
Fewer than 50 families refused in each survey, with the
highest refusal rate being 2% in Dong District.
Figure 1. Reported Measles Cases in Niamey, Niger (2003–2004) (10,880
Patients)
doi:10.1371/journal.pmed.0040016.g001
Figure 2. Reported Measles Cases, N’Djamena, Chad (2004–2005) (8,015 Patients)
doi:10.1371/journal.pmed.0040016.g002
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During the surveyed period, we counted 1,024 measles
cases in Boukoki (AR ¼ 3.8%), 745 in Moursal (3.4%), and
1,429 in Dong District (8.8%) (Figures 4–6; Table 2). The
highest ARs were found in children aged under 5 y (Table 2).
In Boukoki, previous measles vaccination (conﬁrmed by
card) was reported for 37.3% (382/1,024) of patients, with
70% (522/745) reported in Moursal. In Dong District, only
1.0% (15/1,429) of patients had documented measles vacci-
nation. Few cases were in children aged less than 9 mo (the
age of routine vaccination) in each of the three sites: 5.5%
(56/1,024) in Boukoki, 5.6% (42/745) in Moursal, and 4.1% (58/
1,429) in Dong District.
Of measles cases with information on complications, 65.3%
(506/775) of patients in Boukoki, 79.0% (588/744) of patients
in Moursal, and 67.0% (770/1,149) of patients in Dong District
developed respiratory complications; diarrhoeal complica-
tions were reported for 60.1% of patients (466/775) in
Boukoki, 71.7% (521/727) of patients in Moursal, and 66.3%
(762/1,149) of patients in Dong District.
Measles Mortality
The median time between rash onset and death was 9 d in
Boukoki, 6 d in Moursal, and 11 d in Dong District. The
median age of death was 18 mo in Boukoki (interquartile
range [IQR]: 11–33 mo), 19 mo in Moursal (IQR: 10–26 mo),
and 24 mo in Dong District (IQR: 24–36 mo).
For deaths occurring within 30 d of rash onset among
patients with at least 30 d of follow-up, the highest measles
CFR occurred in all sites in children aged less than 5 y (Table
3). When children aged under 5 y were disaggregated into
ﬁner age ranges, CFR declined with age except in Dong
District, where the CFR in 12–35-mo-old children was higher
than that in those under 12 mo (Table 4).
Between 30 and 60 d of rash onset, a total of three deaths
(8.8%) occurred in Boukoki, with six deaths (20.7%) in
Moursal and seven deaths (7.4%) in Dong District. Few deaths
occurred after 60 d of rash onset: one death (2.9%) in
Boukoki, three deaths (10.3%) in Moursal, and six deaths
(6.4%) in Dong District.
Of the 4,792 households visited in Boukoki, 30 reported a
measles death, and of the 816 households reporting measles
cases, 3.4% (28/816) reported at least one death. Of all
households visited in Moursal, 0.5% (17/2,686) reported a
Figure 3. Reported Measles Cases, Adamawa State, Nigeria (2004–2005) (2,505 Patients)
doi:10.1371/journal.pmed.0040016.g003
Table 1. Description of Study Populations in Boukoki, Niamey,
Niger; Moursal, N’Djamena, Chad; and Dong District, Adamawa
State, Nigeria, 2003–2005
Surveyed Population Survey Site
Urban Rural
Boukoki Moursal Dong District
Total 26,795 21,812 16,249
a
,5 y (%) 4,924 (18.4) 3,040 (13.9) 3,354 (20.7)
5–14 y (%) 6,351 (23.7) 5,011 (23.0) 4,555 (28.0)
 15 y (%) 15,520 (57.9) 13,761 (63.1) 8,325 (51.3)
Total number of households 4,792 3,686 2,491
Mean household size 5.6 5.9 6.5
aAge data are missing for 15 persons in the surveyed population.
doi:10.1371/journal.pmed.0040016.t001
Figure 4. Flow Diagram of Measles Cases Included in the Study, Boukoki,
Niamey, Niger (2003–2004)
doi:10.1371/journal.pmed.0040016.g004
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cases, 3.2% reported at least one death (17/533). One or more
measles deaths occurred in 2.9% (71/2,491) of all households
visited in Dong District and in 10.3% (71/690) of all
households with measles cases in Dong District.
One measles death occurred in Boukoki with card-
conﬁrmed measles vaccination, two deaths in Moursal, and
one death in Dong District. Considering parental recall of
vaccination, three deaths occurred in vaccinated individuals
in Boukoki, ten deaths in Moursal, and ﬁve deaths in Dong
District. Approximately half of the deaths in both Boukoki
(16/30) and in Moursal (10/20) reported not having taken
Vitamin A in the 6 mo prior to rash onset or in the month
after rash onset. In Dong District, 62.5% (50/80) reported not
having taken Vitamin A in the 6 mo prior to rash onset or in
the month after rash onset.
There were no reported differences between deaths in
males and females in Boukoki (male-to-female ratio [M:F
ratio] 1.3:1 [17:13, p ¼ 0.79]) or in Moursal (M:F ratio 1.5:1
[12:8, p ¼ 0.75]). In Dong District, a larger proportion of
deaths occurred among females than among males (M:F ratio
0.4:1 [21:59, p , 0.001]), while the M:F ratio in the measles
case population was 1.0.
During our surveys, we also recorded data on all deaths that
occurred during the recall period (results not shown). In all
sites, 50% of all deaths in children aged under 5 y were
attributed to measles. The under-5-y mortality rate in
Boukoki was 0.8 deaths/10,000 persons/d, and in Moursal the
under-5-y mortality rate was 1.0 deaths/10,000 persons/d. In
Dong District, the under-5-y mortality rate was 2.8 deaths/
10,000 persons/d, which is above the conventional threshold
of 2.0 deaths/10,000 persons/d used to characterize a complex
humanitarian emergency.
Access to Health Care
Of measles cases, it was reported that 85.7% (979/1,142) of
patients visited a health-care facility within 30 d after rash
onset in Boukoki, with 73.5% (519/706) in Moursal and 52.8%
(603/1,142) in Dong District. Of patients who consulted a
health-care facility, 95.0% (930) in Boukoki, 85.2% (442) in
Moursal, and 95.2% (574) in Dong District paid for services.
Little information on measles CFR in health-care facilities
was available. In Niamey General Hospital (Boukoki) and
Numan General Hospital (Dong District), the main health-
care facilities to which patients with measles complications
were admitted or referred, 19.0% and 12.9% of patients,
respectively, died during the epidemics. This information was
not available for the epidemic in N’Djamena.
Almost two-thirds (19/30, 63.3%) of deaths attributed to
measles occurred at home in Boukoki and more than half in
Moursal (57.1%, 12/21). Of the 80 deaths in Dong District, 70
occurred at home (87.5%). Of deaths occurring at home in
any of the study sites, none of the patients visited a medical
facility, and the principal reasons were different in each of
the study sites. In Boukoki, the principal reasons provided for
not visiting a medical facility were lack of money (62%) or
that the patient was not seriously ill (11%). In both Moursal
and Dong District, the principal reasons given were that the
patient was treated at home with treatment purchased from a
pharmaceutical vendor or market (49% in both locations);
that traditional medicine was used (27% in Moursal and 19%
in Dong District); and that the patient did not have the money
to pay for the visit (11% in Moursal and 16% in Dong
District).
Discussion
Our results provide recent estimates from a region of sub-
Saharan Africa that has not experienced the progress in
measles control observed in other countries of the region.
The 2.8%–7.0% CFRs found in our study are as high as those
Figure 5. Flow Diagram of Measles Cases Included in the Study, Moursal,
N’Djamena, Chad (2004–2005)
doi:10.1371/journal.pmed.0040016.g005
Figure 6. Flow Diagram of Measles Cases Included in the Study, Dong
District, Adamawa State, Nigeria (2004–2005)
doi:10.1371/journal.pmed.0040016.g006
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countries that were included in our surveys. Similar retro-
spective community studies conducted in Boukoki, Niamey,
Niger after measles epidemics estimated an overall CFR of
6.6% in 1991 [16] and a CFR of 2.4% in children aged under 5
y in 1995 [17]. In a rural area in Niger, a retrospective
community survey that was performed after the 1991–1992
epidemic identiﬁed a CFR of 18.2% in children aged under 5
y [18]. A recent study in Mirriah district in Niger found a CFR
of 9.7% [3]. In N’Djamena, a community survey after a
measles epidemic in 1993 found a mean CFR of 7.4% in
children aged under 5 y [20]. In an urban area of Nigeria in
1995, a CFR of 3.3% was found in the population [19].
The continuing high burden of preventable measles
mortality during these epidemics results from poor access
to appropriate treatment and the incomplete implementa-
tion of the WHO/UNICEF measles mortality–reduction
strategy. In all sites, access to appropriate treatment was
not provided free of charge from the beginning of the
epidemic. In the rural site of Dong District, where the measles
CFR was highest, less than half of all measles patients had
contact with a health-care facility, and in all sites, most
measles deaths occurred at home. Respondents often pre-
ferred to purchase treatment outside of a health-care facility
(e.g., market or pharmaceutical vendor), rather than to seek
treatment at a health-care facility. Moreover, in health-care
facilities admitting patients with more severe measles
complications, excess workload and inappropriate case
management of measles complications may have contributed
to the high measles mortality observed in the principal
referral hospitals in Niamey and Dong District.
The high mortality seen in these three epidemics also
resulted from incomplete implementation of the recommen-
ded strategy for sustainable measles mortality reduction [1].
Routine vaccination programs in these countries have not
been able to consistently provide a high proportion of infants
and young children with measles vaccine through routine
health services. Moreover, vaccination programs in these
countries make limited efforts to reach older children who
failed to receive measles vaccine through routine services.
The absence of recent SIAs, together with chronically low
vaccine coverage, have combined to allow the numbers of
measles-susceptible children to build up to very high levels
and to precipitate these epidemics. Furthermore, outbreak-
response vaccination activities occurred very late in the
epidemic in Niamey and N’Djamena and not at all in Dong
District. It is important to note that SIAs targeting all
children of between 9 mo and 14 y have been implemented in
all three study sites since the completion of our surveys: in
December 2004 in Niger (99% estimated coverage obtained
as a percentage of target population), and in December 2005
in both Nigeria (96%) and Chad (80%). There were no
measles epidemics reported in 2006, although we would not
expect an epidemic immediately after a high-coverage SIA or
a major epidemic.
SIAs may be very effective in quickly reducing measles
mortality [21], but the impact can be sustained only if they are
a component of a comprehensive and long-term measles-
immunization strategy. If national governments do not have
the ability to sustain implementation of a comprehensive
strategy, SIAs may result only in a short-term reduction of
measles deaths. In large countries with poor public health
infrastructures and high birth rates, which is the situation in
the locations investigated here, there are major logistical and
Table 2. Age-Specific Measles ARs in Boukoki, Niamey, Niger; Moursal, N’Djamena, Chad; and Dong District, Adamawa State, Nigeria,
2003–2005
Age (y) Boukoki Moursal Dong District
Patients (Number in Age
Group/Total in Group)
AR (%) Patients (Number in Age
Group/Total in Group)
AR (%) Patients (Number in Age
Group/Total in Group)
AR (%)
,5 840/4,924 17.1 522/3,040 17.2 816/3,354 24.3
5–14 148/6,351 2.3 186/5,011 3.7 525/4,555 11.5
 15 36/15,520 0.2 33/13,761 0.2 88/8,325 1.1
Total 1,024/26,795 3.8 745/21,812 3.4 1,429/16,249 8.8
doi:10.1371/journal.pmed.0040016.t002
Table 3. Measles CFRs in Boukoki, Niamey, Niger; Moursal, N’Djamena, Chad; and Dong District, Adamawa State, Nigeria, 2003–2005
Category of Measles-Attributed Deaths Age Group Boukoki Moursal Dong District
Patients
(Deaths/Total)
CFR (%) Patients
(Deaths/Total)
CFR (%) Patients
(Deaths/Total)
CFR (%)
Measles-attributed deaths   30 d from rash onset All age groups 30/767 3.9 20/706 2.8 80/1,142 7.0
Under 5 y 29/625 4.6 19/473 4.0 68/630 10.8
All measles-attributed deaths All age groups 34/767 4.4 30/706 4.2 93/1,142 8.1
Under 5 y 33/625 5.3 29/473 6.1 81/630 12.9
doi:10.1371/journal.pmed.0040016.t003
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same time, these constraints are only partially responsible for
the high measles burden and should not be used as arguments
not to improve control measures.
Although ARs were similar in all three sites, the CFR was
higher in Dong District. This is likely due to several factors.
First, there was no vaccination intervention and, for half of
reported cases, respondents reported no contact with a
medical facility. Second, MSF and the Ministry of Health
implemented free access to treatment for patients with
measles in April 2005, 6 mo after the start of the epidemic.
Consequently, for most patients included in the survey who
consulted a health-care facility, the treatment was paid for,
with an average of 6 euros per consultation. After free
treatment was provided, measles case attendance increased,
but it was observed that most cases continued to come from
areas adjacent to health-care facilities. This geographic
limitation of rural areas was not observed in the two urban
areas investigated here.
There were several limitations to these studies. Measles
cases that were ascertained during the community surveys
were not laboratory-conﬁrmed, except for ten to 20 cases at
the beginning of each of the outbreaks. This may have
resulted in a classiﬁcation bias resulting in an overestimation
of measles AR and CFRs. In all study sites, measles is a well-
known disease entity. Thus, we would expect the accuracy of
respondents reporting cause of deaths to be high [22], and the
positive predictive value of a case satisfying the clinical case
deﬁnition would also be expected to be high.
As these studies were conducted towards the end of the
epidemics, respondents might have attributed unrelated
deaths to measles. Conversely, we cannot exclude the
possibility that, owing to the long delay between the disease
and the survey, measles infections that occurred at the
beginning of the recall period were not reported. In all three
sites, the majority of measles deaths reported occurred in the
second half of the study period, i.e., during the months of
February, March, and April (73% in Dong District, 70% in
Boukoki, and 79% in Moursal). Furthermore, the denomi-
nator used to estimate measles ARs was the study population,
and not the number of persons susceptible to measles,
thereby underestimating ARs.
Our study-site selection may also not be representative of
the affected areas. Site selection was based on population size
and logistic considerations, thereby favouring areas that are
more accessible. As a result, these areas likely had health-care
facilities capable of detecting measles cases through surveil-
lance and therefore may not be representative of the area as a
whole. We also cannot exclude the possibility that survey
teams may have missed households in the study areas.
However, as survey teams were trained extensively and
returned to households where the head of household was
absent, this is likely to be a very small proportion. An
additional limitation concerns the difﬁculty in ascertaining
age in the populations surveyed. Births and deaths are not
routinely recorded, and the age of children is almost always
imprecise. As these surveys were conducted in only one
neighbourhood of each of the affected areas, our results may
be suitable for extrapolation only to other similar contexts.
We considered only respiratory infections and diarrhoea as
measles complications. For other known complications, we
could not ensure the accuracy of respondents as case
deﬁnitions were complex and could be easily misinterpreted
(e.g., corneal ulcer versus conjunctivitis, encephalitis versus
septic shock). Other complications, for example malnutrition,
were likely to be present in these study populations.
Furthermore, some studies have suggested that mortality
related to measles may be delayed for as long as 1 y after acute
diseases have been observed [23]. In our populations, only a
small proportion occurred after the 30-d window, but
respondents may not have attributed a death occurring more
than 30 d after rash onset to measles.
Measles deaths, unlike some other high-burden diseases in
sub-Saharan Africa (tuberculosis, malaria, and HIV/AIDS),
can be fully prevented by using an effective, safe, and cheap
vaccine under proven vaccination strategies. Governments,
international non-governmental organizations, and interna-
tional partnerships like the Measles Initiative should
strengthen their efforts in those countries where measles
continues to kill thousands of children every year. Recogniz-
ing shortcomings in measles vaccination and mortality-
reduction programs could be the ﬁrst step towards eliminat-
ing measles in Africa [24].
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Table 4. Age-Specific Measles CFR in Boukoki, Niamey, Niger; Moursal, N’Djamena, Chad; and Dong District, Adamawa State, Nigeria,
2003–2005
Age (mo) Boukoki Moursal Dong District
CFR (%) Number of Deaths/Total CFR (%) Number of Deaths/Total CFR (%) Number of Deaths/Total
,12 7.2 8/111 6.8 5/97 10.6 5/47
12–35 4.2 14/335 4.7 11/232 12.8 40/312
36–59 3.9 7/179 1.8 3/168 8.5 23/271
 60 0.7 1/142 0.5 1/209 2.3 12/512
Total 3.9 30/767 2.8 20/706 7.0 80/1,142
doi:10.1371/journal.pmed.0040016.t004
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Editors’ Summary
Background. In most developed countries, measles is often now
regarded as an uncommon and not very serious childhood illness. The
situation in developing countries is totally different; many children get
measles, and the consequences can be severe. The main factor
accounting for this difference is the much greater availability of
vaccination against measles in developed countries. Globally, approx-
imately 410,000 children under the age of 5 y die of measles each year. In
developing countries, the death rate among children with measles is
1%–5%, but in refugee situations and among malnourished children, it
may reach 10%–30%. The complications of the disease include
pneumonia, diarrhea, encephalitis, and corneal scarring, which can lead
to blindness. It costs less than US$1 to vaccinate a child against measles
but, tragically, it remains the leading cause of vaccine-preventable death
among children.
Why Was This Study Done? There are many national and international
initiatives intended to improve measles vaccination rates, and in many
developing countries things are improving; measles death rates in Africa
as a whole are believed to be less than half of what they were 10 y ago.
However, in certain countries—for example in West Africa—serious
measles epidemics do still occur. It has been some years since any major
studies have been conducted to try to establish how many children die
during these epidemics. It is important to know this in order to help with
efforts to improve the situation.
What Did the Researchers Do and Find? They focused on three
epidemicsofmeaslesinWestAfricaandtheirimpactononeneighborhood
in each of three countries that were severely affected: Chad, Niger, and
Nigeria. The total population of these neighborhoods was more than
64,000. The researchers spoke to the heads of households and asked for
information about measles cases. They recorded details of symptoms of
children who were taken ill during the epidemic and the outcome,
includingdeaths.Theyalsonotedwhatactionfamiliestookwhenchildren
had measles. The percentage of children who developed measles was
around 17% in the neighborhoods in Chad and Niger, and 24% in the
Nigerian neighborhood. The death rate among the children who had
measleswasaround4%inChadandNiger,and11%inNigeria.Mostparents
took their children to a health-care facility within 30 d of a rash appearing
but this varied: 86% did so in Chad, 74% in Niger, and 53% in Nigeria.
What Do These Findings Mean? Children in these countries still face an
unacceptably high risk of death from a completely preventable disease.
Much more needs to be done to increase the number of children who
are vaccinated.
Additional Information. Please access these Web sites via the online
version of this summary at http://dx.doi.org/10.1371/journal.pmed.
0040016
  Wikipedia information on measles (note that Wikipedia is an online
encyclopedia that anyone can edit)
  More detailed information on measles may be obtained from
MedlinePlus and the World Health Organization
  Information about the Measles Initiative
  For information about the three countries in this study, consult their
country profiles on the BBC website: Chad, Niger, and Nigeria.
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